DAL PIAZ, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 5.361
EU - Europa 3.201
AS - Asia 1.992
SA - Sud America 198
OC - Oceania 47
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.845
Nazione #
US - Stati Uniti d'America 5.310
RU - Federazione Russa 968
SG - Singapore 588
IT - Italia 540
CN - Cina 538
SE - Svezia 289
IE - Irlanda 283
PL - Polonia 262
UA - Ucraina 261
HK - Hong Kong 254
VN - Vietnam 208
DE - Germania 198
KR - Corea 189
BR - Brasile 159
GB - Regno Unito 144
FI - Finlandia 106
FR - Francia 100
IN - India 75
AU - Australia 47
JO - Giordania 28
JP - Giappone 19
TR - Turchia 19
BD - Bangladesh 18
CA - Canada 18
NL - Olanda 17
MX - Messico 16
SC - Seychelles 14
CO - Colombia 10
IQ - Iraq 9
EC - Ecuador 7
ES - Italia 7
GT - Guatemala 6
NG - Nigeria 6
UZ - Uzbekistan 6
VE - Venezuela 6
AR - Argentina 5
BE - Belgio 5
PE - Perù 5
ZA - Sudafrica 5
AT - Austria 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
ID - Indonesia 3
IL - Israele 3
MY - Malesia 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
SN - Senegal 1
SO - Somalia 1
TG - Togo 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.845
Città #
Santa Clara 1.233
Ashburn 400
Jacksonville 386
Singapore 386
Fairfield 381
Chandler 331
Dublin 283
Warsaw 262
San Jose 259
Buffalo 209
Hong Kong 191
Seoul 184
Seattle 160
Cambridge 159
Woodbridge 149
Hefei 139
Wilmington 125
Milan 122
Los Angeles 118
Beijing 107
Houston 100
The Dalles 71
Princeton 69
Lauterbourg 63
Ho Chi Minh City 57
Hanoi 51
Boardman 50
Dallas 50
Boston 46
Council Bluffs 46
Melbourne 46
Rome 43
Dong Ket 40
Munich 39
Medford 38
New York 38
Ann Arbor 37
Kent 36
Mumbai 36
Helsinki 30
Shanghai 29
Moscow 28
San Diego 27
Philadelphia 23
West Jordan 21
Frankfurt Am Main 17
Tokyo 17
Lawrence 16
Figino 15
Florence 15
London 15
Naples 15
São Paulo 15
Verona 14
Altamura 13
Orem 11
Bologna 10
Da Nang 10
Norwalk 10
Izmir 9
Turin 9
Atlanta 8
Bengaluru 8
Brooklyn 8
Chennai 8
Chicago 8
Groningen 8
Guangzhou 8
Yubileyny 8
Auburn Hills 7
Bari 7
Frankfurt am Main 7
Toronto 7
Abuja 6
Belo Horizonte 6
Dearborn 6
Guatemala City 6
Hillsboro 6
Manchester 6
Turku 6
Curitiba 5
Denver 5
Haiphong 5
Palermo 5
Paris 5
Phoenix 5
Tashkent 5
Amsterdam 4
Andover 4
Brescia 4
Bến Tre 4
Dhaka 4
Fort Worth 4
Fuzhou 4
Guayaquil 4
Hangzhou 4
North Charleston 4
Rio de Janeiro 4
Riyadh 4
Trieste 4
Totale 7.130
Nome #
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 438
1,2,3.4-tetrahydro-1,2-diazepine derivatives from isoxazolo[3,4-d]pyridazin-7-(6H)-ones 315
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 296
ANTINOCICEPTIVE ACTIVITY OF A 3(2H)-PYRIDAZINONE DERIVATE IN MICE 214
4-SUBSTITUTED-5-ACETYL-2-METHYL-6-PHENYL-3(2H)PYRIDAZINONES AS PGE2 AND IL-1 RELEASE INHIBITORS FROM MOUSE ADHERENT MACROPHAGES 212
CHIRAL RESOLUTION AND ABSOLUTE CONFIGURATION OF THE ENANTIOMERS OF 5-ACETYL-2-METHYL-4-METHYLSULFINYL-6-PHENYL-3(2H)-PYRIDAZINONE AND EVALUATION OF THEIR PLATELET AGGREGATION INHIBITORY ACTIVITY 210
5-ACETYL-2-METHYL-4-NITRO-6-PHENYL-3(2H)-PYRIDAZINONE:VERSATILE PRECURSOR TO HETERO-CONDENSED PYRIDAZINONES 206
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 190
4,5-FUNCTIONALIZED 6-PHENYL-3(2H)-PIRIDAZINONES:SYNTHESIS AND EVALUATION OF ANTINOCICEPTIVE ACTIVITY 184
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 183
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 183
GRID-DOCKING STUDY ON LIGANDS ACTING AS INHIBITORS OF THE HUMAN PHOSPHODIESTERASE 4 181
ISOXAZOLO[3,4-D]PYRIDAZIN-7-(6H)-ONE AS A POTENTIAL SUBSTRATE FOR NEW ALDOSE REDUCTASE INHIBITORS 180
La cerimetria applicata alla determinazione potenziometrica di farmaci idrazidici e idrazinici. 179
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 177
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 177
4-Nitro-1,2-oxazoles from hydroximic acid chlorides. 176
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 175
Chloramine-T as titrimetric reagent in potentiometric determination of isoniazid, phenelzine and dihydralazine. 175
N.N-dialchil-ammidi e idrazidi di acidi isossazol-3-carbossilici-4,5-disostituiti 174
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 171
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 171
PHOSPHODIESTERASE 4 INHIBITORS, STRUCTURALLY UNRELATED TO ROLIPRAM, AS PROMISING AGENTS FOR THE TREATMENT OF ASTHMA AND OTHER PATHOLOGIES 168
A NEW TWO-STEP PROCEDURE FOR FUNCTIONALIZED-3(2H)-PIRIDAZINONES THROUGH HOMOLYTIC SUBSTITUTION OF 3-CHLOROPYRIDAZINES 168
Diels-Alder Reactions on 5-Acetyl-2-methyl-4-nitro-6-phenylpyridazin-3(2H)-one: a New Facet of the Pyridazine System 167
Potentiometric titration of antithyroid drugs with mercuric acetate solution. 165
5,6-DINITROPHENYL AND 5-AMINOPHENYL-6-NITROPHENYL ANALOGUES OF THE ACAT INHIBITOR 5,6-DIPHENYL-3-ALKYLAMINOPYRIDAZINONES 162
4,5-FUNCTIONALIZED-3(2H)PYRIDAZINONES: NEW SYNTHETIC AND PHARMACOLOGICAL ASPECTS 159
1H, 13C and 15NNMR assignment of substituted isoxazolo[3,4-d]pyridazin-7(6H)-ones 156
PDE5 Inhibitors and their applications 155
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 154
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 153
MONO- AND DI-SUBSTITUTED 5,6-DIPHENYL-3-ALKYLAMINO-PYRIDAZINES ACTIVE AS ACAT INHIBITORS 152
Gravimetric determination of chlorhexidine using tetraphenylborate ion. 151
NOVEL HETEROCYCLIC-FUSED PYRIDAZINONES AS POTENT AND SELECTIVE PHOSPHODIESTERASE IV INHIBITORS 151
New pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d] pyrimidine Derivatives from 4-Acetyl-5-amino-1,3-diphenylpyrazole 150
HETEROCYCLIC-FUSED 3(2H)-PYRIDAZINONES AS POTENT AND SELECTIVE PDE IV INHIBITORS: FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS AND MOLECULAR MODELLING STUDIES 148
Solid State Photodimerisation Reaction of Some 3-Styrylisoxazolo[3,4-d]pyrida-zin-7(6H)-ones 142
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 141
INDENOPYRIDAZINONE DERIVATIVES AS POTENTIAL ANTISECRETORY AND ANTIULCER AGENTS 140
New Functionalized Pyrazoles from Isoxazolopyridazinones 139
Determinazione potenziometrica di alcuni tireostatici nelle compresse. 138
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-7(6H)-one: a New Heterocyclic Ring System from Isoxazolopyridazinones 137
Ring transformation of 5H-1,2-diazepinones into pyrazoles 136
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 136
SYNTHESIS AND EVALUATION AS PLATELET AGGREGATION INHIBITORS OF 6-PHENYL-2,4-SUBSTITUTED-3(2H)-PYRIDAZINONES AND THEIR RIGID ANALOGUES BENZO[H]CINNOLIN-3,5-DIONES 135
Direct alkylation of pyridazines and related compounds by organolithium reagents 134
5,6-diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltranferase inhibitors 132
SYNTHESIS AND EVALUATION OF SOME 4,5-DISUBSTITUTED 6-PHENYL-3(2H)-PYRIDAZINONES AS HYPOTENSIVE AGENTS 131
new pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 129
Alpha-2-agonist as analgesic agents 128
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 126
Identification et dosage de deux ammonium quaternaires associés (cétylpyridinium et déqualinium) dans un collutoire 125
local antiinflammatory effects and behavioral studies on new PDE4 inhibitors 123
Ultraviolet spectra of styryl isoxazoles. 121
5-[2-(5-nitro-2-furil)vinil] isossazoli-3,4-sostituiti, sintesi e attività microbiologica 121
phenylpiperazinylalkylamino substituted pyridazinones as potent alpha 1 adrenoceptor antagonists 121
Condensazione fra isossazoli aventi un gruppo metilico attivato e benzaldeide. 120
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 120
Determinazione mercurimetrica di derivati dell'acido barbiturico. 117
SYNTHESIS OF 4,5 FUNCTIONALIZED-2-METHYL-6-(SUBSTITUTED ARYL)-3(2H)-PYRIDAZINONES: A NEW GROUP OF POTENT PLATELET AGGREGATION INHIBITORS 116
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 114
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 113
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 112
Uso del tetrafenilborato sodico nella determinazione potenziometrica di basi organiche d'interesse farmaceutico. 103
Derivati nitrofuranici dell'isossazolo e loro attività antitricomonale. 102
Ulteriori ricerche sui derivati del sistema isossazolo[3,4-d]piridazin-7-one. 101
Metodi di determinazione della sparteina con tetrafenilborato. 97
Condensation of some 3-methylisoxazolo[3,4-d] pyrydazin-7(6H)ones with aromatic aldheydes. 96
Totale 10.872
Categoria #
all - tutte 27.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022443 6 55 1 39 19 16 8 21 24 13 128 113
2022/20231.167 105 113 57 85 154 216 163 89 128 1 45 11
2023/2024400 14 52 77 23 17 77 2 67 7 25 31 8
2024/20252.943 91 281 154 435 1.000 450 46 101 143 68 98 76
2025/20263.169 387 492 431 146 280 96 379 110 290 140 49 369
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 10.872